PT  - JOURNAL ARTICLE
ED  - ,
TI  - Rosiglitazone increased heart failure but did not differ from metformin plus sulphonylurea for other CV outcomes at interim analysis
AID  - 10.1136/ebm.12.6.170
DP  - 2007 Dec 01
TA  - Evidence Based Medicine
PG  - 170--170
VI  - 12
IP  - 6
4099  - http://ebm.bmj.com/content/12/6/170.short
4100  - http://ebm.bmj.com/content/12/6/170.full
SO  - Evid Based Med2007 Dec 01; 12